KNCV implementing partner for new LIFT-TB initiative

KNCV Tuberculosis Foundation is one of the implementing partners of the LIFT-TB initiative of TB Alliance, funded by the Republic of Korea. LIFT-TB (Leveraging Innovation for Faster Treatment of Tuberculosis) aims to broaden adoption and scale up of improved tuberculosis (TB) treatment regimens. The initiative will also seek to increase treatment completion rates for drug-resistant forms of TB in some of the countries most affected by this form of TB across the Southeast and Central Asian regions.

The five-year project entails a combined commitment of about US$10.5 million by TB Alliance and the Republic of Korea, through the Global Disease Eradication Fund (GDEF), across the seven target countries: The Philippines, Vietnam, Indonesia, Myanmar, Kyrgyzstan, Uzbekistan, Ukraine . Among other goals, the project will support early commencement of operations research for the six-month, all-oral, three-drug BPaL regimen, being planned by participating countries, consistent with current WHO recommendations. The International TB Research Center from Korea also is a partner on this project.

“KNCV applauds this Republic of Korea -TB Alliance initiative”, says Agnes Gebhard, technical director of KNCV Tuberculosis Foundation. “We look forward to working with the TB Alliance, ITRC and other stakeholders on enabling patient access to improved  TB treatment regimens. These fully oral shorter regimens not only bring hope and cure for patients, but will also facilitate the delivery of care by individual health professionals and an effective response of health systems to overcome drug resistant TB.  KNCV will now apply its earlier experience in introducing new drugs and regimens to the introduction of BPaL under appropriate conditions, including the generation of evidence in operational research to inform wider application and scale-up. These new treatments can save many lives – no time to waste!”

READ MORE about KNCV’s BPaL projects and developments.

READ MORE: LIFT-TB announcement by TB Alliance.

Picture credit: Tristan Bayly

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.